- Home
- RIGL vs BTQ Comparison
RIGL vs BTQ Comparison
Compare RIGL & BTQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RIGL | BTQ |
|---|---|---|
| Founded | 1996 | 1983 |
| Country | United States | Canada |
| Employees | N/A | 35 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 564.7M | 517.7M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | RIGL | BTQ |
|---|---|---|
| Price | $46.86 | $3.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $45.67 | $10.00 |
| AVG Volume (30 Days) | 288.3K | ★ 1.5M |
| Earning Date | 05-05-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1867.68 | N/A |
| EPS | ★ 1.32 | N/A |
| Revenue | ★ $294,282,000.00 | N/A |
| Revenue This Year | N/A | $2,332.99 |
| Revenue Next Year | $12.75 | N/A |
| P/E Ratio | $35.21 | ★ N/A |
| Revenue Growth | ★ 64.15 | N/A |
| 52 Week Low | $24.84 | $2.09 |
| 52 Week High | $52.24 | $16.00 |
Technical Indicators
Market Signals| Indicator | RIGL | BTQ |
|---|---|---|
| Relative Strength Index (RSI) | 66.46 | 47.58 |
| Support Level | $40.05 | $3.14 |
| Resistance Level | $49.10 | $3.80 |
| Average True Range (ATR) | 1.92 | 0.27 |
| MACD | 0.36 | -0.04 |
| Stochastic Oscillator | 90.87 | 27.31 |
Price Performance
Historical ComparisonAbout RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.
About BTQ BTQ Technologies Corp.
BTQ Technologies Corp is engaged in the development of computer-based technology related to post-quantum cryptography, particularly as it applies to blockchain and related technologies, and their protection from the emerging security risk of quantum computing. The company derives revenue from Software licensing. Geographically, the company has a presence in Canada, Taiwan, Australia, and the United States.